Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer

Nutrition and Cancer

Volumn 67, Issue 4, 2015, Pages 543-554

  Alexander, Dominik D ^a,b   Bassett, Julie K ^c   Weed, Douglas L ^d   Barrett, Erin Cernkovich ^e   Watson, Heather ^e   Harris, William ^b,f,g  

^a EpidStat Institute   (United States)

^b Cancer Council Victoria ^*  (United States)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d Lab 20 Strategic Services   (United States)

^e EXPONENT INC   (United States)

^f UNIVERSITY OF SOUTH DAKOTA   (United States)

^g OmegaQuant Analytics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID;

CANCER GRADING; CANCER RISK; CANCER STAGING; DIETARY INTAKE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MALE; PROSPECTIVE STUDY; PROSTATE CANCER; REVIEW; RISK FACTOR; SELF REPORT; BLOOD; FACTUAL DATABASE; META ANALYSIS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BIOMARKERS; DATABASES, FACTUAL; FATTY ACIDS, OMEGA-3; HUMANS; MALE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84929133499     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1015745     Document Type: Review

References (64)

1. American Cancer Society: Cancer Facts & Figures. Atlanta, GA: American Cancer Society, 2014.
2. National Cancer Institute: SEER Stat Fact Sheets: Prostate Cancer: Surveillance, Epidemiology, and End Results Program. National Cancer Institute, National Institutes of Health, 2014. Retrieved from http://seer. cancer.gov/statfacts/html/prost.html
3. International Agency for Research on Cancer: Weight control and physical activity. In: IARC Handbook of Cancer Prevention, Vainio H and Bianchini F (eds). Lyon, France: IARC Press, 2002. Retrieved from http://www.iarc.fr/en/publications/pdfs-online/prev/handbook6/Hand book6.pdf
4. Morote J, Celma A, Planas J, Placer J, Konstantinidis C, et al.: Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressivenes. Actas Urol Esp, 38(4):232-237, 2013.
5. Murphy AB, Akereyeni F, Nyame YA, Guy MC, Martin IK, et al.: Smoking and prostate cancer in a multi-ethnic cohort. Prostate 73, 1518-1528, 2013.
6. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
7. Calder PC: Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 75, 645-662, 2013.
8. Fan C, Zirpoli H, and Qi K: n-3 fatty acids modulate adipose tissue inflammation and oxidative stress. Curr Opin Clin Nutr Metab Care 16 (2), 124-132, 2013.
9. Adkins Y and Kelley DS: Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21, 781-792, 2010.
10. Chapkin RS, Kim W, Lupton JR, and McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81, 187-191, 2009.
11. Serhan CN: Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot Essent Fatty Acids 79, 157-163, 2008.
12. Sfanos KS and De Marzo AM: Prostate cancer and inflammation: the evidence. Histopathology 60, 199-215, 2012.
13. Wang W, Bergh A, and Damber JE: Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 69, 1378-1386, 2009.
14. Bassett JK, Severi G, Hodge AM, MacInnis RJ, Gibson RA, et al.: Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 133, 1882-1891, 2013.
15. Rose DP: Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66 (6, Suppl), 1513S-1522S, 1997.
16. Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, et al.: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 105, 1132-1141, 2013.
17. Chua ME, Sio MC, Sorongon MC, and Morales ML, Jr.: The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis. Can Urol Assoc J 7 (5-6), E333-E343, 2013.
18. Lichtenstein AH, Yetley EA, and Lau J: Application of systematic review methodology to the field of nutrition. J Nutr 138, 2297-2306, 2008.
19. Moher D and Tricco AC: Issues related to the conduct of systematic reviews: a focus on the nutrition field. Am J Clin Nutr 88, 1191-1199, 2008.
20. Nishida C, Uauy R, Kumanyika S, and Shetty P: The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 7 (1A), 245-250, 2004.
21. Kromhout D, Giltay EJ, and Geleijnse JM: n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363, 2015-2026, 2010.
22. Park SY, Wilkens LR, Henning SM, Le Marchand L, Gao K, et al.: Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 20, 211-223, 2009.
23. Rothstein H, Sutton A, and Borenstein M (eds.): Publication Bias in Meta-Analysis: Prevention, Assessment, and Adjustments. Chichester, England: John Wiley and Sons, Ltd, 2005.
24. Comprehensive Meta-Analysis. Version 2.2.046. Englewood, NJ: Biostat.
25. Chavarro JE, Stampfer MJ, Hall MN, Sesso HD, and Ma J: A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. Am J Clin Nutr 88, 1297-1303, 2008.
26. Cheng TY, King IB, Barnett MJ, Ambrosone CB, Thornquist MD, et al.: Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial. Am J Epidemiol 177, 1106-1117, 2013.
27. Epstein MM, Kasperzyk JL, Mucci LA, Giovannucci E, Price A, et al.: Dietary fatty acid intake and prostate cancer survival in Orebro County, Sweden. Am J Epidemiol 176, 240-252, 2012.
28. Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, et al.: Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 172, 566-577, 2010.
29. Wallstrom P, Bjartell A, Gullberg B, Olsson H, and Wirfalt E: A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control 18, 1107-1121, 2007.
30. Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, et al.: A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 12, 64-67, 2003.
31. Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, et al.: Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 80 (1), 204-216, 2004.
32. Crowe FL, Key TJ, Appleby PN, Travis RC, Overvad K, et al.: Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 87, 1405-1413, 2008.
33. Schuurman AG, van den Brandt PA, Dorant E, Brants HA, and Goldbohm RA: Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer 86, 1019-1027, 1999.
34. Koralek DO, Peters U, Andriole G, Reding D, Kirsh V, et al.: A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States). Cancer Causes Control 17, 783-791, 2006.
35. Park SY, Murphy SP, Wilkens LR, Henderson BE, and Kolonel LN: Fat and meat intake and prostate cancer risk: the multiethnic cohort study. Int J Cancer 121, 1339-1345, 2007.
36. Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, et al.: Consumption of fish products across the lifespan and prostate cancer risk. PLoS One 8, e59799, 2013.
37. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, et al.: A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85, 1571-1579, 1993.
38. Mannisto S, Pietinen P, Virtanen MJ, Salminen I, Albanes D, et al.: Fatty acids and risk of prostate cancer in a nested case-control study in male smokers. Cancer Epidemiol Biomarkers Prev 12, 1422-1428, 2003.
39. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, et al.: A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16, 1364-1370, 2007.
40. Brasky TM, Till C, White E, Neuhouser ML, Song X, et al.: Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 173, 1429-1439, 2011.
41. Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, et al.: Fatty acid composition of plasma phospholipids and risk of prostate cancer in a casecontrol analysis nestedwithin the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88, 1353-1363, 2008.
42. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, et al.: Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 71, 545-551, 1997.
43. DePrimo SE, Shinghal R, Vidanes G, and Brooks JD: Prevention of prostate cancer. Hematol Oncol Clin North Am 15, 445-457, 2001.
44. Kipnis V, Subar AF, Midthune D, Freedman LS, Ballard-Barbash R, et al.: Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol 158, 14-21; discussion, 22-26, 2003.
45. Hedrick VE, Dietrich AM, Estabrooks PA, Savla J, Serrano E, et al.: Dietary biomarkers: advances, limitations and future directions. Nutr J 11, 109, 2012.
46. Block RC, Harris WS, and Pottala JV: Determinants of blood cell omega-3 fatty acid content. Open Biomark J 1, 1-6, 2008.
47. Browning LM, Walker CG, Mander AP, West AL, Madden J, et al.: Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr 96, 748-758, 2012.
48. Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, et al.: Determinants of erythrocyte omega-3 Fatty Acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc 2 (6), e000513, 2013.
49. Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, et al.: Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis 225, 425-431, 2012.
50. Salisbury AC, Amin AP, Harris WS, Chan PS, Gosch KL, et al.: Predictors of omega-3 index in patients with acute myocardial infarction. Mayo Clin Proc 86, 626-632, 2011.
51. Sands SA, Reid KJ, Windsor SL, and Harris WS: The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 40, 343-347, 2005.
52. Garneau V, Rudkowska I, Paradis AM, Godin G, Julien P, et al.: Omega-3 fatty acids status in human subjects estimated using a food frequency questionnaire and plasma phospholipids levels. Nutr J 11, 46, 2012.
53. Silverman DI, Reis GJ, Sacks FM, Boucher TM, and Pasternak RC: Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease. Am J Cardiol 66, 860-862, 1990.
54. Katan MB, Deslypere JP, van Birgelen AP, Penders M, and Zegwaard M: Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 2012-2022, 1997.
55. Harris WS and Thomas RM: Biological variability of blood omega-3 biomarkers. Clin Biochem 43, 338-340, 2010.
56. Chua ME, Sio MC, Sorongon MC, and Dy JS: Relationship of dietary intake of omega-3 and omega-6 Fatty acids with risk of prostate cancer development: a meta-analysis of prospective studies and review of literature. Prostate Cancer 2012, 826254, 2012.
57. Sorongon-Legaspi MK, Chua M, Sio MC, and Morales M, Jr.: Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate Cancer 2013, 875615, 2013.
58. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, and Willett WC: Trans fatty acids and cardiovascular disease. N Engl J Med 354, 1601-1613, 2006.
59. Astorg P: Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 15, 367-386, 2004.
60. He C, Qu X, Wan J, Rong R, Huang L, et al.: Inhibiting delta-6 desaturase activity suppresses tumor growth in mice. PLoS One 7 (10), e47567, 2012.
61. Azordegan N, Fraser V, Le K, Hillyer LM, Ma DW, et al.: Carcinogenesis alters fatty acid profile in breast tissue. Mol Cell Biochem 374, 223-232, 2013.
62. Catala A: A synopsis of the process of lipid peroxidation since the discovery of the essential fatty acids. Biochem Biophys Res Commun 399, 318-323, 2010.
63. Legler JM, Feuer EJ, Potosky AL, Merrill RM, and Kramer BS: The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control 9, 519-527, 1998.
64. Welch RW, Antoine JM, Berta JL, Bub A, de Vries J, et al.: Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr 106 (Suppl 2), S3-S15, 2011.